+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Organ Transplant Diagnostics Market by Test Type, Organ Type, Technology, Application, End User - Global Forecast to 2030- Product Image
Organ Transplant Diagnostics Market by Test Type, Organ Type, Technology, Application, End User - Global Forecast to 2030- Product Image
Sale

Organ Transplant Diagnostics Market by Test Type, Organ Type, Technology, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5925160
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The organ transplant diagnostics market is advancing rapidly, propelled by the increasing need for precise compatibility assessment and ongoing innovation in test methodologies. Senior decision-makers face rising pressures to improve transplant outcomes while adapting to evolving regulatory and operational complexities.

Market Snapshot: Organ Transplant Diagnostics Market Size and Growth

The Organ Transplant Diagnostics Market grew from USD 4.46 billion in 2024 to USD 4.80 billion in 2025. It is expected to continue growing at a CAGR of 7.50%, reaching USD 6.89 billion by 2030. This robust growth reflects the sector’s transformation, driven by breakthroughs in genomic sequencing, improvements in immunological assays, and digital advancements that streamline diagnostics workflows across laboratories worldwide.

Scope & Segmentation: In-Depth Coverage of the Organ Transplant Diagnostics Market

  • Test Types: Genetic (DNA sequencing, SNP genotyping), Histocompatibility (crossmatching, HLA typing), Molecular (next generation sequencing, PCR), Serological (ELISA, flow cytometry)
  • Organ Types: Heart, kidney (living and deceased donor), liver (living and deceased donor), lung, pancreas
  • Technologies: ELISA (competitive and sandwich formats), flow cytometry (cell sorting, immunophenotyping), microarray (expression, SNP arrays), next generation sequencing (targeted/whole genome), PCR (digital, real time)
  • Applications: Posttransplant monitoring (infection screening, rejection monitoring), pretransplant matching (crossmatch testing, HLA matching)
  • End Users: Diagnostic centers (hospital labs, independent labs), hospitals (general and transplant centers), research laboratories
  • Regions Covered: Americas (United States, Canada, Mexico, Brazil, Argentina), EMEA (including United Kingdom, Germany, France, Middle East, Africa, and others), Asia-Pacific (China, India, Japan, Australia, Southeast Asia, and more)
  • Major Companies Analyzed: Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Danaher Corporation, bioMérieux SA, QIAGEN N.V., PerkinElmer, DiaSorin S.p.A., Bio-Rad Laboratories, Inc.

Key Takeaways for Senior Decision-Makers

  • Integration of molecular and serological techniques is enabling more robust donor-recipient matching and timelier monitoring of posttransplant health.
  • Digital transformation—via laboratory information management systems and AI-driven analytics—is supporting real-time decision-making and personalized care pathways.
  • Decentralization trends, prompted by point-of-care technologies and portable sequencing, are broadening access in remote and under-resourced settings.
  • Partnerships among academic centers, biotech companies, and transplant networks are fast-tracking the adoption of newly validated biomarkers in clinical routines.
  • Manufacturers are evolving their business models, offering service-based contracts and modular instrument options to manage capital constraints and market volatility.

Tariff Impact: US Policies and Global Supply Chain Response

The 2025 introduction of revised US tariffs on imported reagents, analytical devices, and consumables is influencing supply chain dynamics across the organ transplant diagnostics market. Domestic production initiatives and diversified sourcing have become crucial to maintaining capability. Laboratories are responding by forging partnerships with non-US suppliers, renegotiating contracts, and selecting platforms compatible with a range of reagent sources. These shifts are shaping product adoption timelines and influencing procurement decisions across the industry.

Methodology & Data Sources

This analysis draws from a hybrid research method, combining in-depth reviews of scientific literature and regulatory files, along with structured interviews with leading surgeons, laboratory directors, and diagnostics specialists. The approach triangulates findings between primary and secondary sources to provide reliable, actionable market intelligence for the organ transplant diagnostics space.

Why This Report Matters

  • Supports C-suite executives in pinpointing high-growth segments and aligning investment strategies to rapid shifts in test technology and clinical adoption.
  • Facilitates procurement leaders and operations teams in mitigating risks related to tariffs, regional regulation, and supply chain disruptions.
  • Offers competitive intelligence and segmentation analysis to guide product development, R&D prioritization, and regional expansion initiatives.

Conclusion

The organ transplant diagnostics landscape is being reshaped by advances in testing, digital integration, and adaptive business strategies. This report provides senior decision-makers with a detailed, actionable framework to navigate evolving clinical, technical, and regulatory challenges within the market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Organ Transplant Diagnostics Market, by Test Type
8.1. Introduction
8.2. Genetic
8.2.1. Dna Sequencing
8.2.2. SnP Genotyping
8.3. Histocompatibility
8.3.1. Crossmatching
8.3.2. Hla Typing
8.4. Molecular
8.4.1. Next Generation Sequencing
8.4.2. Pcr
8.5. Serological
8.5.1. Elisa
8.5.2. Flow Cytometry
9. Organ Transplant Diagnostics Market, by Organ Type
9.1. Introduction
9.2. Heart
9.3. Kidney
9.3.1. Deceased Donor
9.3.2. Living Donor
9.4. Liver
9.4.1. Deceased Donor
9.4.2. Living Donor
9.5. Lung
9.6. Pancreas
10. Organ Transplant Diagnostics Market, by Technology
10.1. Introduction
10.2. Elisa
10.2.1. Competitive Elisa
10.2.2. Sandwich Elisa
10.3. Flow Cytometry
10.3.1. Cell Sorting
10.3.2. Immunophenotyping
10.4. Microarray
10.4.1. Expression Arrays
10.4.2. SnP Arrays
10.5. Next Generation Sequencing
10.5.1. Targeted Sequencing
10.5.2. Whole Genome Sequencing
10.6. Pcr
10.6.1. Digital Pcr
10.6.2. Real Time Pcr
11. Organ Transplant Diagnostics Market, by Application
11.1. Introduction
11.2. Posttransplant Monitoring
11.2.1. Infection Screening
11.2.2. Rejection Monitoring
11.3. Pretransplant Matching
11.3.1. Crossmatch Testing
11.3.2. Hla Matching
12. Organ Transplant Diagnostics Market, by End User
12.1. Introduction
12.2. Diagnostic Centers
12.2.1. Hospital Labs
12.2.2. Independent Labs
12.3. Hospitals
12.3.1. General Hospitals
12.3.2. Transplant Centers
12.4. Research Laboratories
13. Americas Organ Transplant Diagnostics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Organ Transplant Diagnostics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Organ Transplant Diagnostics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Roche Holding AG
16.3.2. Abbott Laboratories
16.3.3. Thermo Fisher Scientific Inc.
16.3.4. Siemens Healthineers AG
16.3.5. Danaher Corporation
16.3.6. bioMérieux SA
16.3.7. QIAGEN N.V.
16.3.8. PerkinElmer, Inc.
16.3.9. DiaSorin S.p.A.
16.3.10. Bio-Rad Laboratories, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ORGAN TRANSPLANT DIAGNOSTICS MARKET MULTI-CURRENCY
FIGURE 2. ORGAN TRANSPLANT DIAGNOSTICS MARKET MULTI-LANGUAGE
FIGURE 3. ORGAN TRANSPLANT DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ORGAN TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ORGAN TRANSPLANT DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ORGAN TRANSPLANT DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SNP GENOTYPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY CROSSMATCHING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA TYPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HEART, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DECEASED DONOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVING DONOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DECEASED DONOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVING DONOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LUNG, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PANCREAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY CELL SORTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY IMMUNOPHENOTYPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY EXPRESSION ARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SNP ARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INFECTION SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REJECTION MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY CROSSMATCH TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HLA MATCHING, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 117. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 118. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 119. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 120. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 121. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2018-2030 (USD MILLION)
TABLE 122. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 123. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 124. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 125. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 126. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 127. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 128. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 129. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 130. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 131. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, 2018-2030 (USD MILLION)
TABLE 133. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, 2018-2030 (USD MILLION)
TABLE 134. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 136. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 137. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 138. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 139. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 140. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 141. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2018-2030 (USD MILLION)
TABLE 142. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 143. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 144. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 145. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 147. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 148. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 149. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 150. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 151. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, 2018-2030 (USD MILLION)
TABLE 153. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, 2018-2030 (USD MILLION)
TABLE 154. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 156. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 176. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 179. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 180. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 181. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2018-2030 (USD MILLION)
TABLE 182. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 183. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 184. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 185. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 186. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 187. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 188. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 189. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 190. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 191. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, 2018-2030 (USD MILLION)
TABLE 193. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, 2018-2030 (USD MILLION)
TABLE 194. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 196. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, 2018-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, 2018-2030 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 218. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 220. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 222. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2018-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 224. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 226. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 238. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 239. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 240. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 241. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 242. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2018-2030 (USD MILLION)
TABLE 243. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 244. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 245. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 246. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 247. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 248. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 249. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 250. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 251. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 252. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, 2018-2030 (USD MILLION)
TABLE 254. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, 2018-2030 (USD MILLION)
TABLE 255. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 257. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 258. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 259. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 260. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 261. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 262. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2018-2030 (USD MILLION)
TABLE 263. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 264. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 265. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 266. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 268. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 269. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 270. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 271. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 272. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, 2018-2030 (USD MILLION)
TABLE 274. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, 2018-2030 (USD MILLION)
TABLE 275. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 277. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 278. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 279. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 280. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 281. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 282. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2018-2030 (USD MILLION)
TABLE 283. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 284. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 285. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 286. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 287. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 288. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 289. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 290. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 291. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 292. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY POSTTRANSPLANT MONITORING, 2018-2030 (USD MILLION)
TABLE 294. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRETRANSPLANT MATCHING, 2018-2030 (USD MILLION)
TABLE 295. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 296. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 297. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 298. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 299. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 300. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 301. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 302. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL, 2018-2030 (USD MILLION)
TABLE 303. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 304. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 305. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 306. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 307. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 308. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 309. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 310. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 311. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 312. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Organ Transplant Diagnostics market report include:
  • Roche Holding AG
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Danaher Corporation
  • bioMérieux SA
  • QIAGEN N.V.
  • PerkinElmer, Inc.
  • DiaSorin S.p.A.
  • Bio-Rad Laboratories, Inc.

Table Information

Report AttributeDetails
No. of Pages192
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.8 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.89 Billion
Compound Annual Growth Rate7.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Transplant Diagnostics Market by Diagnostic Application, Technology, Organ Type, End User - Global Forecast to 2030 - Product Image

Transplant Diagnostics Market by Diagnostic Application, Technology, Organ Type, End User - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Organ Transplant Diagnostics Market - A Global and Regional Analysis: Focus on Offering, Application, Technology, Transplant Type, End User, and Country - Analysis and Forecast, 2025-2035 - Product Image

Organ Transplant Diagnostics Market - A Global and Regional Analysis: Focus on Offering, Application, Technology, Transplant Type, End User, and Country - Analysis and Forecast, 2025-2035

  • Report
  • 140 Pages
  • Global
From
Solid Organ Transplantation Rejection Market by Rejection Type, Offering, Type Of Organ Transplant, End User - Global Forecast to 2030 - Product Image

Solid Organ Transplantation Rejection Market by Rejection Type, Offering, Type Of Organ Transplant, End User - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Transplant Diagnostics Market Report by Component, Technology, Organ Type, Application, End User, and Region 2024-2032 - Product Image

Transplant Diagnostics Market Report by Component, Technology, Organ Type, Application, End User, and Region 2024-2032

  • Report
  • 138 Pages
  • Global
From
Organ Transplant Immunosuppressant Drugs Market Size, Share & Trends Analysis Report By Drug Class (Calcineurin Inhibitors, Antiproliferative Agents), By Transplant Type, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Organ Transplant Immunosuppressant Drugs Market Size, Share & Trends Analysis Report By Drug Class (Calcineurin Inhibitors, Antiproliferative Agents), By Transplant Type, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 110 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.